|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

Hip Joint Kinectics as Clinically Meaningful Outcomes for Therapeutic Trials in 4-6 Year Old Boys with Duchenne Muscular Dystropy

Center:

CA-Tarjan Center UCLA, UCEDD

Fiscal Year:

2014

Contact Information:

Eileen Fowler
[email protected]
310-825-4028

Product Description:

Presentation given at AACPDM on Dr. Fowler's research. Duchenne Muscular Dystrophy i a progressive genetic neurological disorder that affects males. Clinically, progressive proximal muscle weakness occurs with loss of ambulation by the age of 11 for most patients. Steroids have become the standard of care and novel therapeutics are currently being developed and tested. We hypothesized that hip joint gait kinetics would be reduced at baseline and improve with 6 months of steroid treatment in 4-6 year old boys with DMD. The results of the study support kinetic gait parameters as valid and sensitive measures for clinical trials in young boys with DMD.

Keyword(s):

Hip joint kinetics, Therapeutic trials, Individuals with Duchenne Muscular Dystrophy, Research, Boys

Product/Publication Type(s):

Conference presentations and posters presented

Target Audience:

Professionals

Alternative Format:

Electronic (disc, CD, 508 compliant web posting)

To Obtain Copies (URL or Email):

[email protected]

COVID-19 Related Data:

N/A